تخطى إلى المحتوى / Skip to content
Evidence Grade Brisk

Revised Cardiac Risk Index (Lee Index)

The Revised Cardiac Risk Index (RCRI), also known as the Lee Index, is a validated tool for predicting major adverse cardiac events (MACE) in patients undergoing non-cardiac surgery. It assesses six independent predictors.

بيانات المريض

أدخل القيم أدناه لحساب النتيجة.

جراحة داخل البطن أو داخل الصدر أو جراحة الأوعية الدموية فوق الإربية
تاريخ من الإصابة باحتشاء عضلة القلب، اختبار جهد إيجابي، ذبحة صدرية، استخدام أدوية النترات، أو وجود موجات Q مرضية في تخطيط القلب
تاريخ من الإصابة بفشل القلب، أو وذمة رئوية، أو ضيق تنفس ليلي انتيابي، أو خراخر في الرئتين من الجانبين، أو صوت قلب ثالث S3
تاريخ من الإصابة بسكتة دماغية أو نوبة نقص تروية عابرة (TIA)
داء السكري الذي يتطلب العلاج بالأنسولين
الكرياتينين في الدم قبل العملية > 2.0 ملغ/ديسيلتر (177 ميكرومول/لتر)

About

The RCRI was developed and validated by Dr. Thomas Lee and colleagues in 1999 using data from 4,315 patients undergoing elective non-cardiac surgery. It identifies six independent predictors of major cardiac complications (death, MI, pulmonary edema, VF/cardiac arrest): high-risk surgery (intraperitoneal, intrathoracic, suprainguinal vascular), ischemic heart disease (history of MI, positive stress test, angina, nitrate use, or Q waves), congestive heart failure, cerebrovascular disease (history of stroke or TIA), insulin therapy for diabetes, and pre-operative serum creatinine >2 mg/dL (177 μmol/L). The risk of MACE increases with score: 0 (0.4%), 1 (1%), 2 (2.4%), 3+ (5.4%).

Formula

RCRI = High-risk surgery (1) + Ischemic heart disease (1) + CHF (1) + Cerebrovascular disease (1) + Insulin-dependent diabetes (1) + Creatinine >2 mg/dL (1)

Each predictor scores 1 point. High-risk surgery: intraperitoneal, intrathoracic, or suprainguinal vascular. Ischemic heart disease: MI, angina, Q waves, positive stress test. CHF: pulmonary edema, S3, rales. Cerebrovascular disease: stroke or TIA. Creatinine: >2 mg/dL or >177 μmol/L.

Score Interpretation

Perioperative cardiac complications affect 1-5% of patients undergoing non-cardiac surgery and are a leading cause of post-operative mortality. The RCRI is the most widely validated cardiac risk prediction tool, endorsed by ESC/ESA guidelines for pre-operative cardiac risk assessment.

Class I — 0–0

MACE risk ~0.4%.

Management: Proceed with surgery. No additional testing needed.

Class II — 1–1

MACE risk ~1.0%.

Management: Proceed. Consider pre-operative ECG.

Class III — 2–2

MACE risk ~2.4%.

Management: Consider pre-operative testing (ECG, echo, possibly stress test).

Class IV — 3+

MACE risk ~5.4%.

Management: Cardiology consultation. Consider stress testing. Optimize cardiac medications.

Reference Ranges

PopulationNormal Range
Adults undergoing elective non-cardiac surgery0 (low risk) to 6 (high risk)
Photo of Pharmacy+ Medical Review Team - Certified Medical Reviewer at PharmacyPlus

Pharmacy+ Medical Review Team

MD, FACC — Cardiology

Expert cardiology review panel.

View medical review board & editorial policy →

Example Calculation

A 75-year-old with prior MI, diabetes on insulin, undergoing open repair of AAA (high-risk surgery). RCRI: high-risk surgery (1) + ischemic heart disease (1) + insulin diabetes (1) = 3 (Class IV, 5.4% MACE risk).

Related Medications

Common Mistakes

Mistake

Counting previous coronary revascularization as ischemic heart disease without active ischemia.

Correction

RCRI counts ischemic heart disease only if active (MI, angina, Q waves, positive stress test, or nitrate use). Prior CABG without active symptoms is not counted.

Frequently Asked Questions

Is RCRI still recommended in current guidelines?
Yes. The 2022 ESC/ESA Guidelines on cardiovascular assessment before non-cardiac surgery recommend RCRI for cardiac risk stratification (Class I, Level B recommendation). However, NSQIP MICA and ACS NSQIP risk calculators provide more individualized risk estimates.

References

  • Lee TH, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043-9.

Run Your Entire Pharmacy on PharmacyPlus

Fast barcode POS, FEFO batch & expiry tracking, instant generic & therapeutic substitution, drug interaction alerts, and clinical dosing calculators in one unified platform.

Start 7-Day Free Trial
Medical Disclaimer: This calculator is intended for use by healthcare professionals for educational and clinical decision support purposes only. It is not a substitute for professional clinical judgment.
تواصل عبر واتساب